MoUMay 11, 2026, 07:37 AM
ASP Isotopes' QLE Signs MOU for HALEU Supply to Europe by 2028
AI Summary
ASP Isotopes Inc.'s wholly-owned subsidiary, Quantum Leap Energy (QLE), has entered into a non-binding Memorandum of Understanding (MOU) with a European nuclear technology company specializing in advanced nuclear reactor development. The MOU outlines a framework for collaboration to supply High Assay Low Enriched Uranium (HALEU) to the European partner, with potential deliveries beginning in 2028 and scaling up through 2036. This agreement is a significant step in QLE's mission to build enrichment capabilities and address the critical challenge of HALEU supply for the advanced nuclear industry.
Key Highlights
- Quantum Leap Energy (QLE), an ASP Isotopes subsidiary, signed an MOU with a European nuclear technology company.
- The MOU establishes a framework for advanced nuclear fuel supply collaboration, specifically for HALEU.
- HALEU will have uranium-235 content greater than 10%.
- Potential HALEU deliveries are estimated to begin in 2028 and scale up through 2036.
- The European partner would provide uranium feedstocks to QLE's planned facilities for enrichment.
- The MOU term extends through December 31, 2030, subject to early termination.
- The collaboration aims to establish reliable HALEU production capabilities for global markets.
Price Impact
More from ASPI